Comment from Thatch Glynnis
AnonymousSupportIndividual
Summary: An individual consumer supports the creation of a safe, regulated pathway for compounded peptides. They argue that providing regulated access helps preserve the patient-provider relationship and prevents patients from seeking unregulated, potentially unsafe alternatives.
I am writing to support patient and physician access to safe, regulated compounded peptides.
As a consumer safely regulated compounded medication has positively affected my health. I am grateful for the pharmacy and physician providers who prescribed what best benefits my health needs.
Compounded peptides, prepared by accredited pharmacies under state and federal oversight, give physicians and pharmacists important tools to care for their patients. Restricting access pushes patients toward an unregulated market and raises costs, which disproportionately affects people managing chronic conditions.
I urge the committee to support a safe, quality, and regulated pathway for these peptides so that the patient-provider relationship is preserved and care stays in accountable channels.
Thank you for considering my comment.